ArticleRSC advances2022
Selenium substituted axitinib reduces axitinib side effects and maintains its anti-renal tumor activity.
Ying Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleRSC advances2022
Ying Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.